PAVMEDLOGONEW15OCT2018.png
PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021
May 13, 2021 09:30 ET | PAVmed Inc.
Dr. David Poppers to present on his initial experience with Lucid’s EsoCheck and EsoGuard NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed” or the “Company”),...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Hold Business Update Conference Call on May 17, 2021
May 03, 2021 09:30 ET | PAVmed Inc.
Company conference call and webcast at 4:30 PM EDT NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,...
Global Industry Executive Debbie White Joins PAVmed Board of Directors
April 27, 2021 09:30 ET | PAVmed Inc.
NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
PAVMEDLOGONEW15OCT2018.png
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
December 18, 2020 09:29 ET | PAVmed Inc.
NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...
PAVMEDLOGONEW15OCT2018.png
PAVmed Announces Registered Direct Offering of its Common Stock
December 11, 2020 09:29 ET | PAVmed Inc.
NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...
PAVMEDLOGONEW15OCT2018.png
PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020
September 08, 2020 09:30 ET | PAVmed Inc.
NEW YORK, Sept. 08, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...
PAVMEDLOGONEW15OCT2018.png
PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update
August 18, 2020 16:14 ET | PAVmed Inc.
Conference call to be held today at 4:30 p.m. Eastern time NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,...
PAVMEDLOGONEW15OCT2018.png
PAVmed Secures $7 Million Convertible Note Financing
August 06, 2020 09:27 ET | PAVmed Inc.
NEW YORK, Aug. 06, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...
PAVMEDLOGONEW15OCT2018.png
PAVmed Subsidiary Lucid Diagnostics Receives Preliminary Payment Determination for EsoGuard™ Esophageal DNA Test
June 11, 2020 09:30 ET | PAVmed Inc.
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that its...
PAVMEDLOGONEW15OCT2018.png
PAVmed Reports Preliminary Fourth Quarter 2019 Financial Results and Provides Business Update
April 09, 2020 16:44 ET | PAVmed Inc.
Conference call to be held today at 4:30 p.m. Eastern time NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,...